ClinConnect ClinConnect Logo
Search / Trial NCT07032233

Assessment of Strength, Balance, and Function in Above-Knee Amputees in Relation to Residual Limb Length

Launched by CEREN KUZU · Jun 13, 2025

Trial Information

Current as of September 12, 2025

Not yet recruiting

Keywords

Transfemoral Amputation Muscle Strength Isokinetic Dynamometry Balance Assessment Functional Capacity Residual Limb Length Prosthetics Postural Control Gait Six Minute Walk Test Mobility

ClinConnect Summary

This clinical trial is studying how the length of the remaining part of the leg after an above-knee amputation affects muscle strength, balance, and overall ability to move. Researchers want to understand if the length of the residual limb and the strength of specific leg muscles influence how well someone can balance and perform everyday activities. This information could help improve rehabilitation and support for people with above-knee amputations.

People who might be eligible for this study are adults between 18 and 50 years old who have had an amputation above the knee on one leg, have been walking with a prosthetic leg for at least six months, and do not have other health issues that affect balance or muscle strength. If you join the study, you will have your muscle strength tested using special equipment, complete balance tests that measure how you distribute your weight, and take a six-minute walk to see how well you can move and how much endurance you have. The study is not yet recruiting participants, and if at any point you experience pain or discomfort, or decide to stop, you can withdraw without any problem. This research aims to better understand mobility after amputation to help create better treatments and support for amputees.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals will be included in the study if they:
  • Are between 18 and 50 years of age
  • Are literate
  • Have unilateral transfemoral amputation
  • Have no cardiovascular, orthopedic, cognitive, or neurological conditions that could negatively affect balance, gait, or muscle strength
  • Are able to ambulate independently with a prosthesis
  • Have been walking for at least 6 months
  • Voluntarily agree to participate in the study
  • Exclusion Criteria:
  • Participants will be excluded from the study if:
  • They develop complications such as pain (rated 3 or higher on the Visual Analog Scale) or stump irritation during the course of the study
  • Their residual limb length is less than 25 cm from the greater trochanter, which exceeds the limitations of the isokinetic dynamometer attachments used in the study
  • They voluntarily withdraw from the study - in such cases, their data will be removed from the records

About Ceren Kuzu

Ceren Kuzu is a clinical trial sponsor dedicated to advancing medical research through the development and management of innovative clinical studies. With a focus on ensuring rigorous scientific standards and patient safety, Ceren Kuzu supports the progression of novel therapies from early-phase trials to late-stage evaluation, contributing to improved healthcare outcomes. Their commitment to ethical research practices and collaboration with multidisciplinary teams underscores their role in facilitating impactful clinical investigations.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported